OVID
Ovid Therapeutics Inc
NASDAQ: OVID · HEALTHCARE · BIOTECHNOLOGY
$2.69
-0.37% today
Updated 2026-04-29
Market cap
$465.47M
P/E ratio
—
P/S ratio
64.19x
EPS (TTM)
$-0.23
Dividend yield
—
52W range
$0 – $3
Volume
3.4M
Ovid Therapeutics Inc (OVID) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+58.8%
Last 4 quarters
Revenue YoY growth
+844.7%
Most recent quarter
EPS YoY growth
+146.2%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-4.5%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-11.1%
2025-11-12
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-16 | $0.06 | +152.8% | $1.97 | $2.01 | +2.0% |
| 2025-11-12 | $-0.17 | -13.3% | $1.35 | $1.20 | -11.1% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.11 | $0.06 | +152.8% | $718000.00 | +844.7% |
| 2025-09-30 | $-0.15 | $-0.17 | -13.3% | $132000.00 | -23.7% |
| 2025-06-30 | $-0.16 | $-0.06 | +62.5% | $6.27M | +3611.2% |
| 2025-03-31 | $-0.21 | $-0.14 | +33.3% | $130000.00 | -12.2% |
| 2024-12-31 | $-0.17 | $-0.13 | +22.2% | $76000.00 | -46.5% |
| 2024-09-30 | $-0.20 | $-0.20 | +1.4% | $173000.00 | +58.7% |
| 2024-06-30 | $-0.22 | $0.12 | +154.5% | $169000.00 | +125.3% |
| 2024-03-31 | $-0.22 | $-0.17 | +22.7% | $148000.00 | +124.2% |
| 2023-12-31 | $-0.05 | $-0.22 | -340.0% | $142000.00 | — |
| 2023-09-30 | $-0.19 | $-0.16 | +15.8% | $109000.00 | — |
| 2023-06-30 | $-0.20 | $-0.18 | +10.0% | $75000.00 | — |
| 2023-03-31 | $-0.17 | $-0.19 | -11.8% | $66000.00 | — |
Frequently asked questions
Has Ovid Therapeutics Inc beaten earnings estimates?
Ovid Therapeutics Inc has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +58.8% over the last 4 quarters.
How does OVID stock react to earnings?
OVID stock has moved an average of -4.5% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Ovid Therapeutics Inc's revenue growth rate?
Ovid Therapeutics Inc reported year-over-year revenue growth of +844.7% in its most recent quarter, with EPS growing +146.2% year-over-year.